Carbonyl Of A Carboxylic Acid Or Salt Thereof Attached Directly To The Benzene Ring Patents (Class 424/9.455)
-
Publication number: 20140065077Abstract: Apparatus and methods are described herein for a container with a unit dose of a concentrated substance that can be diluted and orally consumed using the container. In some embodiments, an apparatus includes a container body that defines an opening in fluid communication with an interior of the container body. A cap is coupled to the container body and encloses the opening. A unit dose of a concentrated medicament or a concentrated contrast agent is disposed within the interior of the container body. The unit dose of concentrated medicament or contrast agent can be diluted to a select dilution strength with a volume of a liquid receivable through the opening and within the interior of the container body. In some embodiments, the apparatus can include a barrier member in which the container body and cap can be disposed to protect the medicament or contrast agent from light and/or moisture.Type: ApplicationFiled: July 3, 2013Publication date: March 6, 2014Inventors: Scott Wayne Hollander, Joel Robert Timberlake, Marjory Kadash
-
Publication number: 20140065076Abstract: Apparatus and methods are described herein for a container with a unit dose of a concentrated substance that can be diluted and orally consumed using the container. In some embodiments, an apparatus includes a container body that defines an opening in fluid communication with an interior of the container body. A cap is coupled to the container body and encloses the opening. A unit dose of a concentrated medicament or a concentrated contrast agent is disposed within the interior of the container body. The unit dose of concentrated medicament or contrast agent can be diluted to a select dilution strength with a volume of a liquid receivable through the opening and within the interior of the container body. In some embodiments, the apparatus can include a barrier member in which the container body and cap can be disposed to protect the medicament or contrast agent from light and/or moisture.Type: ApplicationFiled: August 30, 2012Publication date: March 6, 2014Applicant: OTSUKA PHARMACEUTICAL CO. LTD.Inventors: Scott Wayne Hollander, Joel Robert Timberlake, Marjory Kadash
-
Publication number: 20130071335Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.Type: ApplicationFiled: September 20, 2011Publication date: March 21, 2013Inventor: Elliott C. Lasser
-
Publication number: 20130052143Abstract: An liquid preparation for oral administration in digestive tract imaging, wherein: the preparation comprises an iodine compound, an electrolyte, and a water-soluble polymer; and the iodine content is 1.5 to 12.0 mg/mL.Type: ApplicationFiled: October 31, 2012Publication date: February 28, 2013Applicant: Ajinomoto Co., Inc.Inventor: Ajinomoto Co., Inc.
-
Publication number: 20120321564Abstract: The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs. The invention provides compositions comprising an anionically substituted cyclodextrin, a nephrotoxic drug and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the drug.Type: ApplicationFiled: August 23, 2012Publication date: December 20, 2012Applicant: Verrow Pharmaceuticals, Inc.Inventor: Vernon D. Rowe
-
Patent number: 8147805Abstract: Compositions and methods for dual imaging and for dual chemotherapy and radiotherapy are disclosed. More particularly, the invention concerns compounds comprising the structure X1—Y—X2, wherein Y comprises two or more carbohydrate residues covalently attached to one another, X1 and X2 are diagnostic or therapeutic moieties covalently attached to Y, provided that when Y does not comprise a glucosamine residue, X1 and X2 are diagnostic moieties. The present invention also concerns methods of synthesis of these compounds, application of such compounds for dual imaging and treatment of hyperproliferative disease, and kits for preparing a radiolabeled therapeutic or diagnostic compound.Type: GrantFiled: January 5, 2006Date of Patent: April 3, 2012Assignee: The Board of Regents of The University of T exas SystemInventors: David Yang, Dongfang Yu, Mithu Chanda, Ali Azhdarinia, Changsok Oh, E. Edmund Kim
-
Patent number: 7862800Abstract: This invention relates to sterilized cyanoacrylate adhesive compositions with x-ray imagining capabilities, methods of making such compositions, and methods of using such compositions.Type: GrantFiled: January 10, 2006Date of Patent: January 4, 2011Assignee: Henkel AG & Co. KGaAInventors: Kenneth N. Broadley, Noeleen B. Swords, Clare P. Grealis
-
Publication number: 20100329993Abstract: The present invention provides methods for retaining and expressing physiologically active substances in a target tissue-specific-manner, by administering the physiologically active substances to target submucous tissue. Specifically, the present inventors demonstrated that, when physiologically active substances were directly administered into submucous tissues without using a carrier, the physiologically active substances were effectively and safely retained at the administration sites over long periods without loss and diffusion, and produced the effect acting in a reservoir-like fashion. The physiologically active substances administered as described above were demonstrated to produce the therapeutic effect without having an influence on organs other than the administered organ.Type: ApplicationFiled: June 27, 2008Publication date: December 30, 2010Inventors: Hiroyuki Yoneyama, Kenji Suzuki
-
Patent number: 7666390Abstract: The present invention relates to diethylenetriamine pentaacetic acid (DTPA) derivates and metal complexes thereof, and radiation sources and contrast agents including the metal complexes. More particularly, the present invention relates to DTPA derivatives, which contain iodine and are useful as contrast agents for diagnosing renal function, metal complexes of the DTPA derivatives with 99mTc, 166Ho, 111In, 90Y, 153Sm, 186Re, 188Re, 68Ga, or 177Lu, which are useful as liquid radiation sources for treating vascular stenosis and contrast agents for diagnosing renal function, and radiation sources and contrast agents including the metal complexes. The DTPA derivatives and metal complexes thereof are safe because the metal complexes are excreted via the kidneys and bladder within several minutes from the time of use as liquid radiation sources for treating vascular stenosis, and are cost-effective because they are potentially useful as contrast agents and as agents for diagnosing renal function.Type: GrantFiled: April 25, 2006Date of Patent: February 23, 2010Assignee: Korea Atomic Energy Research InstituteInventors: Young-Don Hong, Sun-Ju Choi, Ok Ja Choi
-
Patent number: 7507394Abstract: Disclosed are novel compositions for embolizing blood vessels which are particularly suited for treating vascular lesions via catheter delivery.Type: GrantFiled: October 28, 2002Date of Patent: March 24, 2009Assignee: Micro Therapeutics, Inc.Inventors: Thomas J. Whalen, Chinh N. Tran, Noah M. Roth, Richard J. Greff
-
Patent number: 6962689Abstract: Disclosed are novel compositions for embolizing blood vessels which are particularly suited for treating vascular lesions via catheter deliver.Type: GrantFiled: October 11, 2001Date of Patent: November 8, 2005Assignee: Micro Therapeutics, Inc.Inventors: Thomas J. Whalen, Chinh N. Tran, Noah M. Roth, Richard J. Greff
-
Patent number: 6531111Abstract: Disclosed are novel compositions for embolizing blood vessels which are particularly suited for treating vascular lesions via catheter delivery.Type: GrantFiled: May 19, 2000Date of Patent: March 11, 2003Assignee: Micro Therapeutics, Inc.Inventors: Thomas J. Whalen, II, Chinh N. Tran, Noah M. Roth, Richard J. Greff
-
Patent number: 6475466Abstract: Disclosed are methods for treating endoleaks arising from endovascular repair of abdominal aortic aneurysms. The disclosed methods involve the in situ sealing of endoleaks after placement of an endovascular prostheses in the abdominal aorta. Sealing of endoleaks is achieved by injection of either a biocompatible polymer or prepolymer fluid composition into the endoleak which composition in situ solidifies to seal the leak. Preferably, the biocompatible fluid composition comprises a contrast agent to allow the clinician to visualize the sealing process.Type: GrantFiled: March 20, 2000Date of Patent: November 5, 2002Assignee: Micro Therapeutics, Inc.Inventors: Charlie Ricci, Bart Dolmatch, Andrew H. Cragg, Richard J. Greff
-
Publication number: 20020031475Abstract: The invention relates to the use of intravenous contrast agents for projection mammography and novel devices for carrying out projection mammography. The invention therefore relates to the use of intravenous contrast agents for producing a diagnostic medium for projection mammography. With the additional intravenous administration of contrast agent, projection mammography attains a sensitivity comparable to the most modern methods, such as magnetic resonance tomography (MRT) while having a wider range of applications and avoiding the cost of MRT. This novel method is simple and can be carried out without special inconvenience for the patients. It a) considerably improves sensitivity for demonstrating focal lesions in the mammae and b) provides additional information on the character of previously detected lesions.Type: ApplicationFiled: April 17, 2000Publication date: March 14, 2002Inventors: ULRICH SPECK, IRTEL VON BRENNDORFF
-
Patent number: 6203779Abstract: Disclosed are methods for treating endoleaks arising from endovascular repair of abdominal aortic aneurysms. The disclosed methods involve the in situ sealing of endoleaks after placement of an endovascular prostheses in the abdominal aorta. Sealing of endoleaks is achieved by injection of either a biocompatible polymer or prepolymer fluid composition into the endoleak which composition in situ solidifies to seal the leak. Preferably, the biocompatible fluid composition comprises a contrast agent to allow the clinician to visualize the sealing process.Type: GrantFiled: March 19, 1999Date of Patent: March 20, 2001Inventors: Charlie Ricci, Bart Dolmatch, Andrew H. Cragg, Richard J. Greff